Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hangartner L, Zinkernagel RM, Hengartner H. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol. 2006;6(3):231–43. https://doi.org/10.1038/nri1783.

CAS  Article  PubMed  Google Scholar 

Antia A, Ahmed H, Handel A, Carlson NE, Amanna IJ, Antia R, et al. Heterogeneity and longevity of antibody memory to viruses and vaccines. PLoS Biol. 2018;16(8): e2006601. https://doi.org/10.1371/journal.pbio.2006601.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Smatti MK, Al Thani AA, Yassine HM. Viral-induced enhanced disease illness. Front Microbiol. 2018;9:2991. https://doi.org/10.3389/fmicb.2018.02991.

Article  PubMed  PubMed Central  Google Scholar 

Eidem S, Tete SM, Jul-Larsen Å, Hoschler K, Montomoli E, Brokstad KA, et al. Persistence and avidity maturation of antibodies to A(H1N1) pdm09 in healthcare workers following repeated annual vaccinations. Vaccine. 2015;33(33):4146–54. https://doi.org/10.1016/j.vaccine.2015.05.081.

Article  PubMed  Google Scholar 

Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, et al. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis. 2008;46(2):186–92. https://doi.org/10.1086/524668.

CAS  Article  PubMed  Google Scholar 

Del Giudice G, Rappuoli R, Didierlaurent AM. Correlates of adjuvanticity: a review on adjuvants in licensed vaccines. Vaccine. 2015;33(33):4146–54. https://doi.org/10.1016/j.vaccine.2015.05.081.

Article  Google Scholar 

Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021;592(7853):283–9. https://doi.org/10.1038/s41586-021-03275-y.

CAS  Article  PubMed  Google Scholar 

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Filia A, Rota MR, D’Ancona FP. Comirnaty (BNT162b2), Il primo vaccino contro il COVID-19 approvato in Europa e in Italia: Istituto Superiore di Sanità -Dipartimentomalattieinfettive; 2021. https://www.epicentro.iss.it/vaccini/covid-19-vaccino-pfizer-biontech

Cavalcanti E, Isgrò MA, Rea D, Di Capua L, Trillò G, Russo L, et al. Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy). Infect Agent Cancer. 2021;16(1):32. https://doi.org/10.1186/s13027-021-00375-2.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. https://doi.org/10.1126/science.abf4063.

CAS  Article  PubMed  Google Scholar 

Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF, et al. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021;384(14):1372–4. https://doi.org/10.1056/NEJMc2101667.

CAS  Article  PubMed  Google Scholar 

Padoan A, Dall’Olmo L, Rocca FD, Barbaro F, Cosma C, Basso D, et al. Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers. Clin Chim Acta. 2021;519:60–3. https://doi.org/10.1016/j.cca.2021.04.006.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Blain H, Tuaillon E, Gamon L, Pisoni A, Miot S, Picot MC, et al. Spike antibody levels of nursing home residents with or without prior COVID-19 3 weeks after a single BNT162b2 vaccine dose. JAMA. 2021;325(18):1898–9. https://doi.org/10.1001/jama.2021.6042.

CAS  Article  PubMed Central  Google Scholar 

Buonaguro FM, Botti G, Ascierto PA, Pignata S, Ionna F, Delrio P, et al. The clinical and translational research activities at the INT – IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic. Infect Agents Cancer. 2020;15:69. https://doi.org/10.1186/s13027-020-00330-7.

CAS  Article  Google Scholar 

Zaccaro DJ, Wagener DK, Whisnant CC, Staats HF. Evaluation of vaccine-induced antibody responses: impact of new technologies. Vaccine. 2013;31(25):2756–61. https://doi.org/10.1016/j.vaccine.2013.03.065.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19. J Clin Investig. 2021;131(12): e149154. https://doi.org/10.1172/JCI149154.

CAS  Article  PubMed Central  Google Scholar 

Pang NY, Pang AS, Chow VT, Wang DY. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Military Med Res. 2021;8:47. https://doi.org/10.1186/s40779-021-00342-3.

CAS  Article  Google Scholar 

Wang L, Zhou T, Zhang Y, Yang ES, Schramm CA, Shi W, et al. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science. 2021;373(6556):eabh1766. https://doi.org/10.1126/science.abh1766.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Budroni S, Buricchi F, Cavallone A, Bourguignon P, Caubet M, Dewar V, et al. Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. NPJ Vaccines. 2021;6(1):78. https://doi.org/10.1038/s41541-021-00337-0.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Tretyn A, Szczepanek J, Skorupa M, Jarkiewicz-Tretyn J, Sandomierz D, Dejewska J, et al. Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccination. Cells. 2021;10(8):1952. https://doi.org/10.3390/cells10081952.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385(24):e84. https://doi.org/10.1056/NEJMoa2114583.

CAS  Article  PubMed  Google Scholar 

Harper DM, DeMars LR. HPV vaccines—a review of the first decade. Gynecol Oncol. 2017;146(1):196–204. https://doi.org/10.1016/j.ygyno.2017.04.004.

CAS  Article  PubMed  Google Scholar 

Wen GP, He L, Tang ZM, Wang SL, Zhang X, Chen YZ, et al. Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans. Nat Commun. 2020;11:3971. https://doi.org/10.1038/s41467-020-17737-w.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, et al. Antibody response to SARS-CoV-2 for more than one year—kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2022;146: 105052. https://doi.org/10.1016/j.jcv.2021.105052.

CAS  Article  PubMed  Google Scholar 

Tsang JS, Dobaño C, VanDamme P, Moncunill G, Marchant A, Othman RB, et al. Improving vaccine-induced immunity: can baseline predict outcome? Trends Immunol. 2020;41(6):457–65. https://doi.org/10.1016/j.it.2020.04.001.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jogalekar MP, Veerabathini A, Gangadaran P. SARS-CoV-2 variants: A double-edged sword? Exp Biol Med (Maywood). 2021;246(15):1721–6. https://doi.org/10.1177/15353702211014146.

CAS  Article  Google Scholar 

Schiøler H, Knudsen T, Brøndum RF, Stoustrup J, Bøgsted M. Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction. Sci Rep. 2021;11(1):24498. https://doi.org/10.1038/s41598-021-04108-8.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chaudhry MZ, Eschke K, Hoffmann M, Grashoff M, Abassi L, Kim Y, et al. Rapid SARS-CoV-2 adaptation to available cellular proteases. J Virol. 2022. https://doi.org/10.1128/jvi.02186-21.

Article  PubMed  PubMed Central  Google Scholar 

Gerdol M, Dishnica K, Giorgetti A. Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein. Virus Res. 2022;310: 198674. https://doi.org/10.1016/j.virusres.2022.198674.

CAS  Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif